CN114010768A - Gynecological external medicine formula - Google Patents
Gynecological external medicine formula Download PDFInfo
- Publication number
- CN114010768A CN114010768A CN202111303241.XA CN202111303241A CN114010768A CN 114010768 A CN114010768 A CN 114010768A CN 202111303241 A CN202111303241 A CN 202111303241A CN 114010768 A CN114010768 A CN 114010768A
- Authority
- CN
- China
- Prior art keywords
- parts
- matrine
- fibronectin
- indigo naturalis
- gynecological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a gynecological external medicine formula which comprises the following raw materials in parts by mass: 3 parts of matrine, 2 parts of indigo naturalis powder, 1 part of fibronectin and a mixed medium. The preparation method comprises the following steps: step one, selecting 3 parts of matrine, 2 parts of indigo naturalis powder and 1 part of fibronectin, and uniformly mixing; step two, putting the mixture obtained in the step one into a machine for stirring, and adding carbomer gel or mixed fatty glyceride for full fusion during stirring; and step three, canning the fusion obtained in the step two. Compared with the prior art, the invention has the advantages that: the product has broad-spectrum insecticidal, antibacterial, HPV virus killing, anti-inflammatory, hemostatic, and rapid healing and repairing functions of damaged mucosa, and has remarkable curative effect on various vaginitis, cervical erosion and cervical cancer, good applicability, and convenient popularization.
Description
Technical Field
The invention relates to the field of gynecological diseases, in particular to a gynecological external medicine formula.
Background
Mycotic vaginitis, trichomonas vaginitis and non-gonococcal vaginitis are common frequently-occurring diseases and are also various in treatment medicines. The external medicine is a lotion for treating gynecological inflammation, is simple to use and has a certain curative effect. In addition, Western medicines such as nystatin and metronidazole have good bactericidal and anti-inflammatory effects on trichomonas and anaerobic bacillus. In the aspect of traditional Chinese medicine, there are also many medicines for treating gynecological inflammation.
Disclosure of Invention
The invention aims to solve the technical problems that the existing gynecological external medicine has poor use effect and high preparation cost, and does not meet clinical requirements.
In order to solve the technical problems, the technical scheme provided by the invention is as follows: the gynecological external medicine formula comprises the following raw materials in parts by mass:
1 part of matrine, 1 part of indigo naturalis powder, 0.5 part of fibronectin and a mixed medium.
Compared with the prior art, the invention has the advantages that: the product has the functions of killing and inhibiting bacteria, killing HPV virus, diminishing inflammation, stopping bleeding and healing and repairing damaged mucous membrane, and has obvious curative effect on vaginitis, cervical erosion and cervical cancer, high adaptability, easy popularization, high safety and reliability and no toxic side effect and untoward reaction.
Further, the feed comprises the following raw materials in parts by mass:
2 parts of matrine, 1.5 parts of indigo naturalis powder, 0.7 part of fibronectin and a mixed medium.
Further, the feed comprises the following raw materials in parts by mass:
3 parts of matrine, 2 parts of indigo naturalis powder, 1 part of fibronectin and a mixed medium.
Further, the mixing medium is carbomer gel or mixed fatty glyceride.
Further, the preparation method comprises the following steps:
step one, selecting 3 parts of matrine, 2 parts of indigo naturalis powder and 1 part of fibronectin, and uniformly mixing;
step two, putting the mixture obtained in the step one into a machine for stirring, and adding carbomer gel or mixed fatty glyceride for full fusion during stirring;
and step three, canning the fusion obtained in the step two.
Detailed Description
The invention is implemented in detail, and the gynecological external medicine formula comprises the following raw materials in parts by mass:
1 part of matrine, 1 part of indigo naturalis powder, 0.5 part of fibronectin and a mixed medium.
The composite material comprises the following raw materials in parts by mass:
2 parts of matrine, 1.5 parts of indigo naturalis powder, 0.7 part of fibronectin and a mixed medium.
The composite material comprises the following raw materials in parts by mass:
3 parts of matrine, 2 parts of indigo naturalis powder, 1 part of fibronectin and a mixed medium.
The mixing medium is carbomer gel or mixed fatty glyceride.
The preparation method comprises the following steps:
step one, selecting 3 parts of matrine, 2 parts of indigo naturalis powder and 1 part of fibronectin, and uniformly mixing;
step two, putting the mixture obtained in the step one into a machine for stirring, and adding carbomer gel or mixed fatty glyceride for full fusion during stirring;
and step three, canning the fusion obtained in the step two.
The working principle of the invention is as follows: the formula is an external gynecological medicament formula, and raw materials comprise 3 parts of matrine, 2 parts of indigo naturalis powder, 1 part of fibronectin and a mixed medium, wherein the mixed medium is carbomer gel or mixed fatty glyceride.
The preparation method comprises the following steps: mixing the above three materials, stirring mechanically, mixing with carbomer gel, and packaging.
The using method comprises the following steps: injecting 3-5g of gel into vagina every day.
Example (b):
in this embodiment, the manufacturing method is improved, and the raw materials include 3 parts of matrine, 2 parts of natural indigo powder, 1 part of fibronectin and a mixed medium, wherein the mixed medium is carbomer gel or mixed fatty glyceride. Mixing the above three materials, stirring mechanically, mixing with carbomer gel, making into suppository, and packaging.
The using method comprises the following steps: 2-3g of the suppository is taken every day and is inserted into the vagina.
Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention, and that variations, modifications, substitutions and alterations can be made in the above embodiments by those of ordinary skill in the art without departing from the principle and spirit of the present invention.
Claims (5)
1. The gynecological external medicine formula is characterized by comprising the following raw materials in parts by mass:
1 part of matrine, 1 part of indigo naturalis powder, 0.5 part of fibronectin and a mixed medium.
2. The formula for the external gynecological medicine according to claim 1, which is characterized by comprising the following raw materials in parts by mass:
2 parts of matrine, 1.5 parts of indigo naturalis powder, 0.7 part of fibronectin and a mixed medium.
3. The formula for the external gynecological medicine according to claim 1, which is characterized by comprising the following raw materials in parts by mass:
3 parts of matrine, 2 parts of indigo naturalis powder, 1 part of fibronectin and a mixed medium.
4. The gynecological external use drug formulation according to claim 1, characterized in that: the mixing medium is carbomer gel or mixed fatty glyceride.
5. The gynecological external use medicine formula according to claim 1, characterized in that the preparation method is as follows:
step one, selecting 3 parts of matrine, 2 parts of indigo naturalis powder and 1 part of fibronectin, and uniformly mixing;
step two, putting the mixture obtained in the step one into a machine for stirring, and adding carbomer gel or mixed fatty glyceride for full fusion during stirring;
and step three, canning the fusion obtained in the step two.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111303241.XA CN114010768A (en) | 2021-11-05 | 2021-11-05 | Gynecological external medicine formula |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111303241.XA CN114010768A (en) | 2021-11-05 | 2021-11-05 | Gynecological external medicine formula |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114010768A true CN114010768A (en) | 2022-02-08 |
Family
ID=80061200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111303241.XA Withdrawn CN114010768A (en) | 2021-11-05 | 2021-11-05 | Gynecological external medicine formula |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114010768A (en) |
-
2021
- 2021-11-05 CN CN202111303241.XA patent/CN114010768A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102793785B (en) | Chinese rhubarb-baical skullcap root-amur corktree bark itching-relieving liniment and preparation method thereof | |
| CN104688786B (en) | A kind of externally-applied medicinal composition and its preparation method and application | |
| CN101601750B (en) | Specific beriberi medicament | |
| CN101507731A (en) | Chitosan uterus-neck antibiotic film and preparation method thereof | |
| CN101612278B (en) | Medicine for external application for treating pyogenic type contaminated wounds | |
| CN101890181B (en) | Swine fibrin glue powder inhalation and preparation method and application thereof | |
| CN114010768A (en) | Gynecological external medicine formula | |
| CN101049337B (en) | Medication for curing furuncle, sore, and carbuncle, and preparation method | |
| CN101306163A (en) | Zhixue shengji powder | |
| CN102718693B (en) | Carbazochrome sodium sulfonate compound and composition thereof | |
| CN101375835A (en) | External-use sertaconazole nitrate suppositorium | |
| CN106963974A (en) | A kind of adhesive bandage containing alkannin and preparation method thereof | |
| CN1799639A (en) | Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method | |
| CN110368429A (en) | Prevent and treat the Chinese medicine composition and preparation method thereof that bacillary enterogastritis draws dysentery | |
| CN118286318B (en) | Preparation method of ulcer capsule and application of ulcer capsule in preparation of medicine for repairing gastric mucosal injury | |
| CN105125483A (en) | Florfenicol injection solution for veterinary use and preparation method of injection solution | |
| CN1190196C (en) | Anti-inflammation antibiotic external used synthesized medicine, soluble hemostatic gauze and method for making the same | |
| CN100379464C (en) | Soluble hemostatic gauze for diminishing inflammation, killing bacteria and calming pain, and its making method | |
| CN110227144A (en) | A kind of elimination gynaecological imflammation pathogenic bacteria and the antibacterial peptide targeting preparation of HPV viruse and preparation method thereof | |
| CN105213326A (en) | A kind of preparation method of clindamycin phosphate for injection lyophilized powder | |
| CN110251716A (en) | A kind of wound care gel dressing and preparation method thereof | |
| CN116531450A (en) | Five-cereal worm wound healing agent and preparation method thereof | |
| CN101406539A (en) | Medicament for treating thrombocytopenia after chemotherapy | |
| CN108578418A (en) | A kind of composition of medicine for treating diabetes wound surface in refractory to treatment complication | |
| CN109498710B (en) | Hemostatic Mongolian medicine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220208 |